Medical anticancer treatment of lung cancer associated with comorbidities: A review.

Authors : Sculier JP, Botta I, Bucalau AM, Compagnie M, Eskenazi A, Fischler R, Gorham J, Mans L, Rozen L, Speybrouck S, Wang X, Meert AP, Berghmans T
Year : 2015
Journal : Lung Cancer
Volume : 87(3)
Pages : 241-248

Systematic qualitative review of randomised trials conducted in NSCLC with a noninferiority or equivalence design.

Authors : Paesmans M, Grigoriu B, Ocak S, Roelandts M, Lafitte JJ, Holbrechts S, Berghmans T, Meert AP, Moretti L, Danyi S, Pasleau F, Ameye L, Van Meerhaeghe A, Sculier JP
Year : 2015
Journal : Eur. Respir. J.
Volume : 45(2)
Pages : 511-24

Le cours du groupe d'oncologie thoracique de la société de pneumologie de langue française(GOLF) et le certificat interuniversitaire européen d'oncologie thoracique (Editorial)

Authors : Sculier JP, Berghmans T
Year : 2014
Journal : Rev Mal Respir
Volume : 6(4)
Pages : 303-4

Contribution of mineralogical analysis in thoraciconcology: The example of asbestos. Answer from Morelle et al.

Authors : Morelle I, Berghmans T, CsToth I, Sculier JP, Meert AP
Year : 2014
Journal : Rev Mal Respir
Volume : 31(9)
Pages : 875-6

The patient with lung cancer in intensive care.

Authors : Meert AP, Berghmans T, Sculier JP
Year : 2014
Journal : Rev Mal Respir
Volume : 31(10)
Pages : 961-974

Pulmonary Malignancies” “Pulmonary complications of HIV. Edited by Charles Feldman, Eva Polverino, Julio A. Ramirez. ERS/Monograph 66 (chapt 14)

Authors : Sculier JP, Meuleman N, Meert AP, Berghmans T
Year : 2014
Journal : Book
Volume : chapt 14
Pages : 186-198

Thérapies ciblées : quel traitement pour quel patient ?

Authors : Berghmans T
Year : 2014
Journal : Rev Mal Respir
Volume : 6(4)
Pages : 459-69

Guidelines of clinical practice made by the European Lung Cancer Working Party: updates.

Authors : Berghmans T, Cortot A, CsToth I, Garcia C, Giner-Marco V, Grigoriu B, Holbrechts S, Lafitte JJ, Meert AP, Moretti L, Paesmans M, Remmelink M, Richez M, Roelandts M, Scherpereel A, Tulippe C, Van Houtte P, Sculier JP
Year : 2014
Journal : Rev Med Brux
Volume : 35(3)
Pages : 132-3

Management of resectable non-small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party.

Authors : Berghmans T
Year : 2014
Journal : Rev Med Brux
Volume : 35(3)
Pages : 145-59

Small cell lung cancer: What are the treatment results in routine management?

Authors : Sculier JP, Berghmans T, Meert AP
Year : 2014
Journal : Lung Cancer
Volume : 84(2)
Pages : 101-2

Oncological intensive care: 2012 year's review].

Authors : Sculier JP, Berghmans T, Meert AP
Year : 2014
Journal : Rev Med Brux
Volume : 35(1)
Pages : 22-7

Contribution of identification of occupational exposure in thoracic oncology: A Belgian experience.

Authors : Morelle I, Berghmans T, CsToth I, Sculier JP, Meert AP
Year : 2014
Journal : Rev Mal Respir
Volume : 31(3)
Pages : 221-9

Updates in oncology.

Authors : Sculier JP, Meert AP, Berghmans T
Year : 2014
Journal : Eur Respir Rev
Volume : 23(131)
Pages : 69-78

TNM Classification and Clinicopathological Factors: What Is Helpful for Adjuvant Chemotherapy Decision after Lung Cancer Resection?

Authors : Sculier JP, Berghmans T, Meert AP
Year : 2014
Journal : J Thorac Oncol
Volume : 9(3)
Pages : 266-70

The lung cancer patient at the emergency department: A three-year retrospective study.

Authors : Gorham J, Ameye L, Berghmans T, Sculier JP, Meert AP
Year : 2013
Journal : Lung Cancer
Volume : 80(2)
Pages : 203-8.

Thoracic oncology: annual review.

Authors : Sculier JP, Berghmans T, Meert AP
Year : 2013
Journal : Rev Med Brux
Volume : 34(2)
Pages : 100-11

An atypical presentation of bronchial adenocarcinoma.

Authors : Langouo Fontsa M, CsToth I, Berghmans T, Feoli F, Meert AP
Year : 2013
Journal : Rev Med Brux
Volume : 34(3)
Pages : 181-3

An ELCWP phase III trial comparing ifosfamide and cisplatin regimens in advanced NSCLC.

Authors : Berghmans T, Lafitte JJ, Scherpereel A, Paesmans M, Lecomte J, Marco VG, Meert AP, Leclercq N, Sculier JP
Year : 2013
Journal : Anticancer Res
Volume : 33(12)
Pages : 5477-82

Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study.

Authors : Berghmans T, Ameye L, Willems L, Paesmans M, Mascaux C, Lafitte JJ, Meert AP, Scherpereel A, Cortot AB, CsToth I, Dernies T, Toussaint L, Leclercq N, Sculier JP
Year : 2013
Journal : Lung Cancer
Volume : 82(2)
Pages : 340-5

BRAVISSIMO: 12-month results from a large scale prospective trial.

Authors : Bosiers M, Deloose K, Callaert J, Maene L, Beelen R, Keirse K, Verbist J, Peeters P, Schroë H, Lauwers G, Lansink W, Vanslembroeck K, + collaborators (among others :, Berghmans T, Setacci C
Year : 2013
Journal : J Cardiovasc Surg (Torino)
Volume : 54(2)
Pages : 235-53